Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "ticker"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. Added

TDQS

A4.8/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the annotations (readOnly, idempotent, openWorld, non-destructive), the description discloses cross-source fan-out, soft-failure for the USPTO PatentsView API, the meaning of empty sections as real "no data" rather than bugs, resolved:false behavior for private companies, and fallback chains like GDELT→GNews. This is exceptional transparency.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is front-loaded with examples and a crisp one-line purpose, and every sentence carries useful operational detail. However, it is a very long single-paragraph block; splitting it into sections would improve scannability, so it is not fully concise.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a complex tool with no output schema, the description enumerates all returned sections (cik, recent_filings, fundamentals, patents, federal_contracts, fda_products, hiring, news, LEI, sources_used/sources_failed), explains edge cases, and documents failure semantics. Nothing essential is missing for correct invocation.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The schema already covers both parameters at 100%, so the baseline is 3. The description adds meaningful semantics beyond the schema: zero-padded CIK format, interchangeability of "company" and "ticker", name resolution via SEC EDGAR, and examples for each input shape.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description immediately identifies the tool as a full cross-source profile of a US public company via natural-language intents like "Tell me about X" and "brief me on Tesla". It names its explicit output sections and contrasts itself with chaining single-pack SEC/XBRL/news lookups, so an agent can clearly distinguish it from sibling research tools.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives an explicit usage directive: "ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view." It also states the accepted input shapes, the private-company behavior, and that person/place coverage is not yet available, providing clear when-to-use and implied when-not-to-use guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

Many tools overlap significantly in purpose, especially the ask_pipeworx variants (standard, beta, grounded) and deep_research, as well as the polymarket arbitrage/edges/fill_risk/kalshi_spread suite. It would be hard for an agent to reliably choose the correct tool without deep understanding of subtle distinctions.

Naming Consistency3/5

Tool names mostly use snake_case, but there is no consistent prefix or verb pattern. Some names are descriptive phrases (e.g., scream_void_scream, compare_entities) while others are vague (e.g., forget, recall). The mix of 'pipeworx_' prefix on some tools and lack of it on others adds inconsistency.

Tool Count3/5

32 tools is on the high side for a data research server, given the overlapping functionality. Some tools could be merged (e.g., the ask_pipeworx variants, polymarket tools). However, the count is not excessive enough to be unmanageable, and each tool serves a specific niche.

Completeness4/5

The server covers a broad range of data sources and prediction market analysis, with tools for research, comparison, monitoring, and memory. Minor gaps exist (e.g., no tool to update stored memories or manage subscriptions beyond CRUD), but core workflows are well-supported.